In this study, we present an innovative human model of TDP43 proteinopathy that allows us to trigger cytoplasmic mislocalization of endogenous non-mutated TDP43 on demand in healthy control iPSC-MNs at scale (Figure 1A). This evidence concerns the gene TARDBP and proteostasis deficiencies.